Bristol-Myers Squibb Beats Earnings Estimates and More - Presented by: The Aol. On Network

Bristol-Myers Squibb reported higher than expected quarterly earnings on Tuesday, helped by cost cuts and lower taxes. There were concerns over a possible delay in completing its marketing application for a high-profile cancer drug. BMY posted Q1 earnings of 56 cents per share, beating estimates of 43 cents a share, while revenue dipped to $3.81 billion, missing estimates of $3.89 billion. Bristol-Myers Squibb also announced the acquisition of iPierian for $175 million.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 17.03 0.08 ▲ 0.47%
YHOO $ 38.65 2.28 ▼ 5.57%
BABA $ 89.89 4 ▼ 4.26%
RAD $ 5.11 0.24 ▼ 4.49%
AAPL $ 101.06 0.10 ▲ 0.10%
SIRI $ 3.52 0.05 ▼ 1.40%
VALE $ 11.44 0.56 ▼ 4.67%
QQQ $ 99.05 0.93 ▼ 0.93%

As of 9/22/2014, 04:15 PM
More Most Active